Baclofen Tablets: Suppliers & Bulk Manufacturers
Available Forms: Tablet
Available Strengths: 10 mg and 20 mg
Reference Brands: Lioresal, Gablofen(US & EU)
Category:
Multiple sclerosis
Baclofen is a muscle relaxant that acts as a GABA-B receptor agonist, inhibiting nerve signals in the spinal cord. It reduces muscle spasticity, relieves muscle stiffness, and improves mobility. Benefits include decreased muscle spasms, enhanced flexibility, and better quality of life for patients with spasticity-related conditions like multiple sclerosis and spinal cord injury.
Baclofen Tablets: is available in Tablet
and strengths such as 10 mg and 20 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Baclofen Tablets: is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Baclofen Tablets: can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Baclofen tablets, marketed as Lioresal, are approved in the US by the FDA and in the EU via EMA for treating spasticity in multiple sclerosis, spinal cord injury, and other neurological conditions. Regulatory approval requires a comprehensive dossier including clinical efficacy, safety data, manufacturing quality, and pharmacovigilance plans. In the US, the FDA reviews detailed clinical trial and manufacturing information, while the EMA ensures compliance with regional safety and quality standards.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing